Bristol-Myers Squibb Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 10c, Updattes FY Guidance
October 31, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $6.01 billion versus the consensus estimate of $5.89 billion.
GUIDANCE:
Bristol-Myers Squibb sees Q4 2019 EPS of $4.25-$4.35, versus the consensus of... More
